ArticleBiochemistry and biophysics reports2025
Activation of the AKT-mTOR pathway confers selpercatinib resistance in thyroid cancer cells harboring the
Masatsugu Amitani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it